Citation Impact
Citing Papers
Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate
2019 StandoutScienceNobel
miR-15 and miR-16 induce apoptosis by targeting BCL2
2005 Standout
Immunomodulatory properties of mesenchymal stromal cells
2007 Standout
Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment
2018 StandoutNobel
Cited2 Is an Essential Regulator of Adult Hematopoietic Stem Cells
2009
Injectable antibacterial conductive nanocomposite cryogels with rapid shape recovery for noncompressible hemorrhage and wound healing
2018 Standout
Hif-2α is not essential for cell-autonomous hematopoietic stem cell maintenance
2013 StandoutNobel
SF3B1 deficiency impairs human erythropoiesis via activation of p53 pathway: implications for understanding of ineffective erythropoiesis in MDS
2018
Therapeutic potential of antisense Bcl‐2 as a chemosensitizer for cancer therapy
2004
Cellular and Gene Expression Responses Involved in the Rapid Growth Inhibition of Human Cancer Cells by RNA Interference-mediated Depletion of Telomerase RNA
2005 StandoutNobel
DNA damage checkpoints in stem cells, ageing and cancer
2012
Ferroptosis as a p53-mediated activity during tumour suppression
2015 StandoutNature
p53 and metabolism
2009
Rapamycin induces pluripotent genes associated with avoidance of replicative senescence
2013
Telomere dysfunction in ageing and age-related diseases
2022
The emerging role of p53 in stem cells
2011
Metabolic Regulation of Hematopoietic Stem Cells in the Hypoxic Niche
2011 StandoutNobel
Hallmarks of aging: An expanding universe
2023 Standout
Biodegradable luminescent porous silicon nanoparticles for in vivo applications
2009 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Otto Warburg's contributions to current concepts of cancer metabolism
2011 Standout
GSVA: gene set variation analysis for microarray and RNA-Seq data
2013 Standout
G‐Quadruplexes: Targets in Anticancer Drug Design
2008
The growing applications of click chemistry
2007 Standout
ROS Function in Redox Signaling and Oxidative Stress
2014 Standout
New plays in the p53 theater
2010
PRC2 mediated H3K27 methylations in cellular identity and cancer
2015
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
DNA damage in aging, the stem cell perspective
2019
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Acquisition of G0 state by CD34-positive cord blood cells after bone marrow transplantation
2010
Regulation of cancer cell metabolism
2011 Standout
Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell Content
2010
mTOR: from growth signal integration to cancer, diabetes and ageing
2010 Standout
Identification of NUP98 abnormalities in acute leukemia: JARID1A (12p13) as a new partner gene
2006
Anti‐aging activity of the Ink4/Arf locus
2009
Intrinsically disordered proteins in cellular signalling and regulation
2014 Standout
Programmed Cell Senescence during Mammalian Embryonic Development
2013 Standout
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
2011 Standout
Stem Cells: Hype and Reality
2002
The cancer stem cell: premises, promises and challenges
2011 Standout
The application of DNA and RNA G-quadruplexes to therapeutic medicines
2011
d(G3T4G4) forms unusual dimeric G-quadruplex structure with the same general fold in the presence of K+, Na+ or NH 4 +
2004
Revealing the world of RNA interference
2004 StandoutNatureNobel
New cancer targets emerging from studies of the Von Hippel‐Lindau tumor suppressor protein
2010 StandoutNobel
Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib
2008
Genetics of therapy-related myelodysplasia and acute myeloid leukemia
2008
N-fused porphyrin with pyridinium side-arms: a new class of aromatic ligand with DNA-binding ability
2011
Clonal evolution in cancer
2012 StandoutNature
Gene function correlates with potential for G4 DNA formation in the human genome
2006
The Hallmarks of Aging
2013 Standout
Cellular mechanisms and physiological consequences of redox-dependent signalling
2014 Standout
20 years studying p53 functions in genetically engineered mice
2009
Mdm2 Is Required for Survival of Hematopoietic Stem Cells/Progenitors via Dampening of ROS-Induced p53 Activity
2010
Preservation of Fertility in Patients with Cancer
2009 Standout
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Autophagy in immunity and inflammation
2011 StandoutNature
The first 30 years of p53: growing ever more complex
2009 Standout
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Mechanisms that Regulate Stem Cell Aging and Life Span
2013
Quadruplex DNA: sequence, topology and structure
2006 Standout
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
2013 Standout
Unraveling the Molecular Pathophysiology of Myelodysplastic Syndromes
2011
FIP200 is required for the cell-autonomous maintenance of fetal hematopoietic stem cells
2010
Supramolecular Coordination: Self-Assembly of Finite Two- and Three-Dimensional Ensembles
2011 Standout
Acute Myeloid Leukemia
2015 Standout
Identification and transcriptome analysis of erythroblastic island macrophages
2019 StandoutNobel
Mechanisms of Stem Cell Self-Renewal
2009
G‐Quadruplex DNA Structures and Organic Chemistry: More Than One Connection
2009
Stabilization of G-Quadruplex DNA by Highly Selective Ligands via Click Chemistry
2006
Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin
2013
Telomerase reverse transcriptase protects ATM-deficient hematopoietic stem cells from ROS-induced apoptosis through a telomere-independent mechanism
2011
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Correlative imaging of ionic transport and electronic structure in nano Li0.5FePO4 electrodes
2019 StandoutNobel
Apoptosis related to telomere instability and cell cycle alterations in human glioma cells treated by new highly selective G-quadruplex ligands
2005
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
2008 Standout
Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia
2013
The development of anticancer ruthenium(ii ) complexes: from single molecule compounds to nanomaterials
2017 Standout
A novel telomerase template antagonist (GRN163) as a potential anticancer agent.
2003
Ex vivo maintenance of hematopoietic stem cells by quiescence induction through Fbxw7α overexpression
2010
Adult hematopoietic stem cells lacking Hif-1α self-renew normally
2016 StandoutNobel
How I treat idiopathic thrombocytopenic purpura (ITP)
2005
Artificial Molecular Machines
2015 Standout
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
2011 StandoutScience
Molecular mechanisms of resistance of leukemia to imatinib mesylate
2003
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Promotion of direct reprogramming by transformation-deficient Myc
2010 StandoutNobel
Cu-Catalyzed Azide−Alkyne Cycloaddition
2008 StandoutNobel
Heterocyclic Nanographenes and Other Polycyclic Heteroaromatic Compounds: Synthetic Routes, Properties, and Applications
2016 Standout
Water-Soluble Ruthenium(II) Complexes with Chiral 4-(2,3-Dihydroxypropyl)-formamide Oxoaporphine (FOA): In Vitro and in Vivo Anticancer Activity by Stabilization of G-Quadruplex DNA, Inhibition of Telomerase Activity, and Induction of Tumor Cell Apoptosis
2015
Works of Goro Sashida being referenced
Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders
2013
Regulation of Hematopoietic Stem Cell Quiescence - A Novel Role for p53.
2007
Telomeres and telomerase in hematologic neoplasia
2002
p53 Regulates Hematopoietic Stem Cell Quiescence
2009
Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways
2003
Telomerase inhibition enhances apoptosis in human acute leukemia cells: possibility of antitelomerase therapy
2003
t(7;11)(p15;p15) chronic myeloid leukaemia
developed into blastic transformation showing a novel
NUP98/HOXA11 fusion
2002
Risk factor analysis in myelodysplastic syndrome patients with del(20q): prognosis revisited
2006
Monoclonal constitution of neutrophils detected by PCR-based human androgen receptor gene assay in a subset of idiopathic thrombocytopenic purpura patients
2002
Identification and functional signature of genes regulated by structurally different ABL kinase inhibitors
2007
The p53 tumor suppressor protein is a critical regulator of hematopoietic stem cell behavior
2009
Non-Lethal Ionizing Radiation Promotes Aging-Like Phenotypic Changes of Human Hematopoietic Stem and Progenitor Cells in Humanized Mice
2015
Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia
2006
Stress hematopoiesis reveals abnormal control of self-renewal, lineage bias, and myeloid differentiation in Mll partial tandem duplication (Mll-PTD) hematopoietic stem/progenitor cells
2012
Cyclin C Regulates Human Hematopoietic Stem/Progenitor Cell Quiescence
2009
Telomere dynamics in myelodysplastic syndrome determined by telomere measurement of marrow metaphases.
2003
Inhibition of human telomerase enhances the effect of the tyrosine kinase inhibitor, imatinib, in BCR-ABL-positive leukemia cells.
2002
Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia
2012
BCL-2 antisense oligonucleotide genasense is active against imatinib-resistant BCR-ABL-positive cells.
2003
Depletion of Sf3b1 impairs proliferative capacity of hematopoietic stem cells but is not sufficient to induce myelodysplasia
2014